Creative Biolabs provides integrated physical and organoleptic measurement, IR fingerprinting, HPLC, and UPLC analytical services for live biotherapeutic products, helping QC, analytical development, and formulation teams convert scattered appearance, physicochemical, and component data into batch-comparable methods, release-ready trends, and practical specification recommendations.
Live biotherapeutics analytical development teams often need to connect visible product attributes, chemical fingerprints, bioactive components, excipients, fermentation-derived metabolites, and trace safety indicators into one coherent QC package. When appearance checks, IR spectra, HPLC assays, and UPLC methods are developed separately, results may be difficult to compare across strains, matrices, batches, and stability time points.
Creative Biolabs helps LBP developers build practical analytical combinations that support preclinical product characterization, batch trending, method suitability review, and release-oriented decision making. Our service integrates physical and organoleptic observations with IR, HPLC, and UPLC readouts so analytical findings can guide formulation, process optimization, and specification planning.
Link appearance, reconstitution, moisture-sensitive properties, IR fingerprints, and chromatographic peaks to the same sample history.
Select IR, HPLC, and UPLC conditions that match the LBP matrix, expected analytes, sensitivity needs, and development stage.
Convert analytical outputs into batch-comparison tables, trend summaries, specification proposals, and follow-on QC recommendations.
Creative Biolabs integrates physical and organoleptic measurement with IR, HPLC, and UPLC analytical testing in one coordinated service block, helping LBP teams connect visible product attributes, chemical fingerprints, active components, trace analytes, and batch-trending results.
Physical and organoleptic measurement is the first layer of practical quality control for LBP intermediates and final products. We evaluate visible appearance, color, odor, powder flow tendency, cake integrity, reconstitution behavior, pH-relevant observations, turbidity, sedimentation, and sample handling sensitivity according to the LBP dosage form and matrix.
| Test Area | Service Value |
|---|---|
| Appearance and organoleptic profile | Controlled observation of color, odor, morphology, caking, clumping, and visible heterogeneity. |
| Reconstitution and handling | Assessment of dispersibility, sedimentation, foam tendency, and sample-preparation behavior. |
| Batch and stability trending | Comparison across development lots, formulation variants, storage time points, and stress conditions. |
| Specification recommendation | Practical acceptance-range suggestions that can be refined with IR, HPLC, UPLC, potency, and stability data. |
IR, often combined with aquaphotomics or near-infrared water spectral analysis, has been applied to monitor the growth of probiotic bacteria. It is time-efficient and allows rapid, chemical-free, non-invasive in vivo assessment, providing an opportunity for researching live microorganisms in the cultivation process.
Creative Biolabs utilizes this method to measure bacterial growth rate, maximal optical density, low-pH tolerance, and bile tolerance. The huge amount of spectral data can be used as a reference for the research and diagnostics of various species, as well as identification and discrimination of bacterial species or strains at very low concentrations.
Quick, inexpensive, sensitive, and high-accuracy.
HPLC is an effective analytical technique for the determination of active components during the cultivation process and for targeted component analysis in LBP intermediates or final products.
Creative Biolabs utilizes this method to identify and quantify active prebiotic ingredients, which may promote the survival, colonization, and activity of probiotic strains in the gastrointestinal tract. We can detect various bioactive substances excreted by probiotic bacteria, including but not limited to biogenic amines, lactic acid, butyrate, (+)-catechin, and (-)-epicatechin.
Simple, precise, rapid, and reliable.
UPLC, evolved from HPLC, is a completely new system design with advanced technology. It is also applied to the sensitive and selective determination of trace amounts of active compounds during the cultivation process of LBPs.
Creative Biolabs utilizes this method to identify and quantify active prebiotic ingredients and potential toxins of therapeutic LBPs. It can help evaluate the quality and safety of prebiotic drug products. Usually, UPLC is used in combination with tandem mass spectrometry, such as UPLC-MS/MS, for fraction analysis.
Ultra-efficient, sensitive, fast, and compatible with multianalyte methods.
Creative Biolabs designs each analytical project around the product matrix, intended comparison, sample availability, and decision point, so physical observations and instrumental data can be interpreted together.
Review dosage form, viable organism sensitivity, excipients, storage condition, and target analyte list.
Define extraction, dilution, centrifugation, filtration, quenching, or reconstitution steps that protect analyte integrity.
Evaluate IR fingerprints, HPLC conditions, UPLC sensitivity, specificity, repeatability, and matrix effects.
Deliver batch tables, chromatogram summaries, specification suggestions, and follow-on testing recommendations.
The final data package is organized for analytical development, QC/QA review, formulation decisions, and partner-facing technical discussions. Each deliverable is designed to make next-step decisions easier.
| Deliverable | Included Content | Decision Value |
|---|---|---|
| Physical and organoleptic summary | Appearance records, reconstitution observations, handling notes, and sample-condition flags. | Helps distinguish normal product variability from process or storage drift. |
| IR fingerprint report | Spectral acquisition notes, reference-data alignment, identity or growth-monitoring interpretation, and comparative fingerprints. | Supports rapid screening, culture comparison, and phenotypic stability review. |
| HPLC/UPLC method package | Sample preparation, chromatographic conditions, suitability observations, analyte quantification, and representative chromatograms. | Supports targeted component testing, impurity review, and release-method planning. |
| Batch trend and specification proposal | Lot-comparison tables, stability time-point summaries, and provisional acceptance criteria. | Helps QC/QA and formulation teams prioritize confirmatory testing and refine specifications. |
Recent research on probiotic production showed that Fourier transform infrared spectroscopy can discriminate Lactiplantibacillus plantarum strains under different growth conditions and support monitoring of phenotypic stability during repeated propagation. The figure shows linear discriminant analysis of IR spectra, illustrating how spectral datasets can separate strains and detect whether a target strain remains grouped through process-relevant passages. For LBP teams, this supports the practical value of fast spectral checks during cultivation, banking, and early lot-comparison work.
This evidence matters for LBP analytical development because IR fingerprints can complement physical observations and chromatographic assays, creating a faster first-line view of culture identity, drift, and batch comparability. When paired with HPLC or UPLC data on active ingredients, metabolites, and potential impurity signals, spectral findings become easier to interpret as part of a QC strategy. Creative Biolabs supports this type of integrated service by pairing IR fingerprinting with HPLC/UPLC component analysis, sample preparation control, and trend-ready reporting.
Fig.1 2D scatterplot of all spectra and broth 37°C strain passages. 1,2
Creative Biolabs combines microbiology-aware sample handling, analytical method selection, and development-stage reporting so LBP teams can move from scattered test results to usable quality decisions.
Methods are selected with viability, excipient interference, water activity, lyophilized matrices, and biological variability in mind.
Physical tests, IR, HPLC, and UPLC are aligned as one package rather than delivered as disconnected data files.
Reports focus on batch comparability, method suitability, trend interpretation, and specification planning.
Findings can be extended into QC analytical testing, final product assays, potency testing, and stability programs.
Physical, IR, HPLC, and UPLC testing can be combined with broader QC, final-product, stability, and potency programs when your team needs a more complete analytical development package.
Analytical development, QC/QA, formulation, and preclinical CMC teams use this service when physical observations, IR fingerprints, and chromatographic results need to be organized into one batch-comparable package.
Yes. We evaluate target analytes, matrix complexity, required sensitivity, expected throughput, and sample volume before recommending HPLC, UPLC, or UPLC-MS/MS-compatible approaches.
They do when they are controlled and trended. Appearance, odor, reconstitution, sedimentation, or clumping changes can flag formulation, storage, or processing issues that should be interpreted alongside IR, HPLC, UPLC, viability, and stability data.
Yes. The deliverables can include lot-comparison tables, trend summaries, method suitability observations, and provisional specification recommendations that help teams decide which tests should move into more formal QC workflows.
Useful inputs include product matrix, strain or consortium information, formulation composition, available batch history, target analytes, storage conditions, planned release attributes, and any existing chromatograms or physical observation records.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.